No insider purchase over the last 90 days. The latest, by Yi Lin, was filed 06 Jul 2026.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 41 declarations
At Beauty Farm Medical and Health Industry Inc., a health care company listed in Hong Kong, nearly everything is a purchase: 32 purchases worth EUR 1,921,999 (median EUR 62,735) against a single sale of EUR 8,572, signed by Li Yang, Director, on May 29, 2023. That is 97% purchases among open-market trades, and 26 of the 33 filings are marked as clustered.
On December 3, 2025, three directors bought on the same day for EUR 150,324 each: Li Fangyu, Li Yang and Lian Songyong. From December 3, 2025 to January 2, 2026, 3 filers bought for EUR 951,250 in total. Li Yang is the most frequent filer, with 13 filings of which 12 purchases; Li Fangyu has 10, Lian Songyong 7 and Yi Lin 3, all purchases.
The record holds 11 filings in 2023, 11 in 2025 and 11 in 2026, and the 22 of the last twelve months are all purchases. Market capitalisation is HKD 4.2 billion, with 63% of the capital held by insiders. For 32 purchases a 90-day result is stored: a median of minus 18%, with 3% of results positive. These are recorded past results, not a forecast.
Purchases our model currently ranks for the recommendations list.
All recommendations